Statistics for Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Total visits
| views | |
|---|---|
| Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | 1 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 1 |
| November 2024 | 0 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| 40425_2019_Article_559.pdf | 26 |
Top country views
| views | |
|---|---|
| Canada | 1 |
Top city views
| views | |
|---|---|
| Calgary | 1 |